Patrick S Moore

Q: What Schools Are Affiliated With Patrick S Moore

Patrick S Moore is affiliated with the following schools: University of Verona, University of Illinois College of Medicine, Stanford University, University of Pittsburgh, Columbia University, University of Liverpool, National University of Ireland, Institute of Cancer Research, University of California, Berkeley, Kanazawa University

Patrick S Moore's AcademicInfluence.com Rankings

Patrick S Moore

Computer Science

#4655

World Rank

#4911

Historical Rank

Computational Linguistics

#488

World Rank

#496

Historical Rank

Machine Learning

#982

World Rank

#997

Historical Rank

Artificial Intelligence

#1205

World Rank

#1227

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Patrick S Moore's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Patrick S Moore Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Patrick S Moore's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. (1994) (5672)
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. (1995) (2793)
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma (2008) (1668)
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). (1996) (1526)
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. (1995) (1167)
Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV (1996) (956)
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma (1996) (859)
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus (2008) (667)
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen (1996) (653)
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae (1996) (617)
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. (1996) (613)
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. (1995) (603)
Why do viruses cause cancer? Highlights of the first century of human tumour virology (2010) (602)
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (505)
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. (1997) (494)
Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) (1998) (471)
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen (1997) (465)
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. (1999) (441)
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma (1996) (417)
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. (2000) (405)
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens (2010) (398)
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. (2006) (390)
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway (1997) (373)
Cyclin encoded by KS herpesvirus (1996) (361)
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors (2009) (356)
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma (1996) (343)
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays (2009) (339)
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. (2011) (335)
Genetic profile of 22 pancreatic carcinoma cell lines (2001) (330)
Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 (2001) (319)
The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1 (1997) (307)
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. (1997) (294)
A Kaposi’s Sarcoma-associated Herpesvirus-encoded Cytokine Homolog (vIL-6) Activates Signaling through the Shared gp130 Receptor Subunit* (1997) (271)
Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs (2012) (268)
Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus (2009) (263)
Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. (1999) (261)
A sensitive non-radioactive northern blot method to detect small RNAs (2010) (252)
Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. (1992) (240)
Merkel Cell Polyomavirus Expression in Merkel Cell Carcinomas and Its Absence in Combined Tumors and Pulmonary Neuroendocrine Carcinomas (2009) (238)
Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. (1997) (236)
INTERCONTINENTAL SPREAD OF AN EPIDEMIC GROUP A NEISSERIA MENINGITIDIS STRAIN (1989) (229)
Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity (2002) (228)
KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. (2000) (225)
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. (1998) (224)
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. (1996) (222)
Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? (2003) (219)
Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. (1996) (214)
Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis (2001) (210)
Merkel cell carcinoma: incidence, mortality, and risk of other cancers. (2010) (195)
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. (1990) (193)
Characterization and Cell Cycle Regulation of the Major Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter (1999) (189)
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities (2018) (183)
Merkel cell carcinoma: a virus-induced human cancer. (2012) (177)
Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. (2011) (160)
Increasing Kaposi's sarcoma‐associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 (1998) (158)
High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. (2001) (158)
Molecular virology of Kaposi's sarcoma-associated herpesvirus. (2001) (153)
Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7. (2013) (148)
The Minimum Replication Origin of Merkel Cell Polyomavirus Has a Unique Large T-Antigen Loading Architecture and Requires Small T-Antigen Expression for Optimal Replication (2009) (146)
Group A meningococcal carriage in travelers returning from Saudi Arabia. (1988) (141)
KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. (1999) (138)
Cloning and expression of a smooth muscle caldesmon. (1989) (133)
Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. (1999) (132)
Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. (2006) (129)
Global epidemiology of meningococcal disease (1989) (129)
Circular DNA tumor viruses make circular RNAs (2018) (127)
Survivin Is a Therapeutic Target in Merkel Cell Carcinoma (2012) (125)
Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. (1996) (122)
Cellular and Viral Factors Regulating Merkel Cell Polyomavirus Replication (2011) (121)
Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. (1996) (119)
Human Transcriptome Subtraction by Using Short Sequence Tags To Search for Tumor Viruses in Conjunctival Carcinoma (2007) (115)
CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation (2015) (110)
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mimics Epstein-Barr Virus EBNA1 Immune Evasion through Central Repeat Domain Effects on Protein Processing (2007) (105)
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells (2003) (104)
Mortality rates in displaced and resident populations of central Somalia during 1992 famine (1993) (103)
MCV and Merkel cell carcinoma: a molecular success story. (2012) (102)
Inhibition of HIV Infection by Caffeoylquinic Acid Derivatives (1993) (101)
Body Cavity-Based Malignant Lymphoma Containing Kaposi Sarcoma-Associated Herpesvirus in an HIV-Negative Man with Previous Kaposi Sarcoma (1996) (101)
Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q. (2001) (100)
Transmission of human herpesvirus 8 by blood transfusion. (2007) (99)
Constituents of Eriobotrya japonica. A study of their antiviral properties. (1992) (99)
Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. (1999) (99)
Role of disease‐causing genes in sporadic pancreatic endocrine tumors: MEN1 andVHL (2001) (98)
Asymptomatic Primary Merkel Cell Polyomavirus Infection among Adults (2011) (97)
Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms (2002) (95)
First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. (1998) (94)
Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. (2015) (93)
Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. (1998) (92)
Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. (1998) (90)
GUIDELINES FOR ARBOVIRUS SURVEILLANCE PROGRAMS IN THE UNITED STATES (1993) (89)
Large T and small T antigens of Merkel cell polyomavirus. (2015) (87)
The T Antigen Locus of Merkel Cell Polyomavirus Downregulates Human Toll-Like Receptor 9 Expression (2013) (85)
The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). (2000) (83)
Genetic abnormalities in pancreatic cancer (2003) (83)
Multicolor microRNA FISH effectively differentiates tumor types. (2013) (81)
Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. (1999) (81)
A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. (1992) (78)
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation (2006) (78)
Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model (2015) (75)
Antagonism between high pressure and anesthetics in the thermal phase-transition of dipalmitoyl phosphatidylcholine bilayer. (1979) (74)
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. (2004) (71)
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data (2005) (70)
Outbreak of Japanese encephalitis on the island of Saipan, 1990. (1993) (70)
Merkel Cell Polyomavirus Large T Antigen Disrupts Lysosome Clustering by Translocating Human Vam6p from the Cytoplasm to the Nucleus* (2011) (69)
Molecular approaches to the identification of unculturable infectious agents. (1996) (66)
Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. (1998) (66)
Allelotype of pancreatic acinar cell carcinoma (2000) (62)
Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. (2010) (62)
Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma. (1996) (61)
Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. (2007) (59)
Human oncogenic viruses: nature and discovery (2017) (59)
Detection of human papillomavirus DNA in pterygia from different geographical regions (2003) (57)
Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes (2011) (57)
Detection of meningitis epidemics in Africa: a population-based analysis. (1992) (56)
Restricted Protein Phosphatase 2A Targeting by Merkel Cell Polyomavirus Small T Antigen (2015) (56)
Merkel Cell Polyomavirus Positive Merkel Cell Carcinoma Requires Viral Small T Antigen For Cell Proliferation (2013) (56)
The epidemiology of HIV‐associated Kaposi's sarcoma: the unraveling mystery (1996) (54)
Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection? (1999) (53)
Observations on the inhibition of HIV-1 reverse transcriptase by catechins. (1992) (53)
Sex chromosome anomalies in pancreatic endocrine tumors (2002) (52)
Asymmetric assembly of Merkel cell polyomavirus large T-antigen origin binding domains at the viral origin. (2011) (51)
Characterization of Viral and Human RNAs Smaller than Canonical MicroRNAs (2009) (51)
Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. (2001) (49)
Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation (2016) (47)
Surveillance and control of meningococcal meningitis epidemics in refugee populations. (1990) (47)
Molecular features of primary mediastinal B‐cell lymphoma: involvement of p16INK4A, p53 and c‐myc (1999) (47)
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. (2013) (45)
Characterization of an ATP-dependent DNA strand transferase from human cells (1987) (45)
Transcriptional Analysis of Latent and Inducible Kaposi's Sarcoma-Associated Herpesvirus Transcripts in the K4 to K7 Region (2005) (45)
The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. (2011) (45)
Kaposi sarcoma-associated herpesvirus and primary and secondary pulmonary hypertension. (2005) (45)
Interleukin‐1B (IL1B) and interleukin‐6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia (2008) (44)
Nonrandom chromosomal imbalances in primary mediastinal b‐cell lymphoma detected by arbitrarily primed PCR fingerprinting (1999) (44)
Persistence in the population: epidemiology and transmisson -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (43)
The conundrum of causality in tumor virology: the cases of KSHV and MCV. (2014) (42)
Infectious disease surveillance during emergency relief to Bhutanese refugees in Nepal. (1994) (42)
Use of a Multiantigen Detection Algorithm for Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection (2006) (42)
A Kaposi ’ s Sarcoma-associated Herpesvirus-encoded Cytokine Homolog ( vIL-6 ) Activates Signaling through the Shared gp 130 Receptor Subunit (1997) (41)
Response of Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Xenografts to a Survivin Inhibitor (2013) (41)
SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivo (2003) (41)
Kaposi’s Sarcoma-Associated Herpesvirus-Encoded circRNAs Are Expressed in Infected Tumor Tissues and Are Incorporated into Virions (2020) (40)
Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells. (2005) (39)
John Snow's legacy: epidemiology without borders (2013) (38)
Survey for human polyomaviruses in cancer. (2016) (38)
Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes. (1996) (38)
Risk factors for adverse outcome in persons with pneumococcal pneumonia. (1995) (38)
Protein-mediated viral latency is a novel mechanism for Merkel cell polyomavirus persistence (2017) (37)
Mechanism-based Inactivation of Dopa Decarboxylase by Serotonin* (1996) (37)
Merkel cell polyomavirus T antigens promote cell proliferation and inflammatory cytokine gene expression. (2015) (36)
Role of nutritional status and weight loss in HIV seroconversion among Rwandan women. (1993) (35)
Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label. (1998) (35)
Successful xenografting of cryopreserved primary pancreatic cancers (2001) (35)
Epidemiologic aspects of a St. Louis encephalitis epidemic in Jefferson County Arkansas, 1991. (1993) (35)
Complex Alternative Cytoplasmic Protein Isoforms of the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Generated through Noncanonical Translation Initiation (2012) (34)
Human herpesvirus 8 variants (1998) (34)
Twenty Years of KSHV (2014) (33)
VZV: pathogenesis and the disease consequences of primary infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (33)
Lack of evidence for direct involvement of Merkel cell polyomavirus (MCV) in chronic lymphocytic leukemia (CLL). (2010) (33)
Kaposi ’ s Sarcoma-Associated Herpesvirus LANA 2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p 53 (2000) (32)
The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET (2014) (31)
Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. (1993) (31)
Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how? (1999) (31)
Non‐random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping (2001) (30)
Alteration of chromosome arm 6p is characteristic of primary mediastinal B‐cell lymphoma, as identified by genome‐wide allelotyping (2001) (30)
Role of IRF4 in IFN-Stimulated Gene Induction and Maintenance of Kaposi Sarcoma–Associated Herpesvirus Latency in Primary Effusion Lymphoma Cells (2013) (30)
The epidemiology of KSHV and its association with malignant disease -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (29)
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas. (2004) (29)
Dietary regulation of the activities of ornithine decarboxylase and S-adenosylmethionine decarboxylase in rats. (1983) (29)
Information Integration in Juror Decision Making (1995) (29)
Cerebrospinal meningitis epidemics. (1994) (28)
Common Commensal Cancer Viruses (2017) (28)
Chromosomal alterations detected by comparative genomic hybridization in nonfunctioning endocrine pancreatic tumors. (2005) (28)
Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel. (2000) (27)
Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. (2000) (26)
Kaposi’s Sarcoma-Associated Herpesvirus (2009) (26)
The porcine LH/hCG receptor. Characterization and purification. (1985) (25)
Kaposi's sarcoma findings. (1995) (25)
Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting (2017) (25)
Effect of urban traffic, individual habits, and genetic polymorphisms on background urinary 1-hydroxypyrene excretion. (2007) (25)
Reactivation and lytic replication of KSHV -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (24)
Posttransplant human herpes virus 8 infection and seroconversion in a Kaposi's sarcoma affected kidney recipient transplanted from a human herpes virus 8 positive living related donor. (1998) (23)
National surveillance of Lyme disease, 1987-1988. (1989) (23)
KSHV manipulation of the cell cycle and apoptosis (2007) (23)
Human Immunodeficiency Virus (HIV) Seroprevalence in Persons Attending STD Clinics in the United States, 1985–1987 (1989) (22)
Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion. (1990) (22)
Trichinellosis acquired in the United Kingdom (2001) (22)
Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba. (2004) (22)
Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping. (2001) (22)
Introduction to the human γ-herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (21)
Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation (1997) (21)
Merkel Cell Polyomavirus Encodes Circular RNAs (circRNAs) Enabling a Dynamic circRNA/microRNA/mRNA Regulatory Network (2020) (20)
Corrected prevalence of Kaposi's sarcoma (KS)-associated herpesvirus infection prior to onset of KS. (1997) (19)
Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion (2005) (19)
KSHV-induced oncogenesis -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (19)
Stable gene amplification and overexpression of sodium- and potassium-activated ATPase in HeLa cells (1986) (18)
Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase. (1995) (18)
Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding (2014) (18)
Regulation of tyrosine aminotransferase by insulin and cyclic AMP: similar effects on activity but opposite effects on transcription. (1989) (18)
Identification and Characterization of Novel Rat Polyomavirus 2 in a Colony of X-SCID Rats by P-PIT assay (2016) (18)
Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E) (2019) (18)
Primate betaherpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (17)
Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer (2001) (17)
Microsporidia: a new sexually transmissable cause of urethritis. (1996) (17)
Alphaherpes viral genes and their functions -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (17)
Immunobiology and host response -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (17)
Sirolimus and Other Mechanistic Target of Rapamycin Inhibitors Directly Activate Latent Pathogenic Human Polyomavirus Replication (2020) (16)
Comparative analysis of herpesvirus-common proteins -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (16)
Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV8) and the Etiology of KS (2002) (16)
Comparative analysis of the genomes -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (15)
Comparative virion structures of human herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (15)
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear β-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression (2005) (15)
Atypical measles following immunization with killed measles vaccine. (1970) (14)
St. Louis encephalitis in Arkansas. (1992) (14)
Pathogenesis and disease -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (13)
Entry of alphaherpesviruses into the cell -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (13)
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis (2002) (13)
Genetic Alterations in Primary Mediastinal B-cell Lymphoma: An Update (2001) (13)
Overexpression of the Sm-like proto-oncogene in primary and metastatic pancreatic endocrine tumors. (2002) (13)
Insulin-mediated regulation of tyrosine aminotransferase in rat hepatoma cells: inhibition of transcription and inhibition of enzyme degradation. (1989) (13)
Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas (2002) (12)
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma (2000) (12)
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker (2005) (12)
SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems (2021) (11)
HHV-6A, 6B, and 7: persistence in the population, epidemiology and transmission -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (11)
Transplanting cancer: donor-cell transmission of Kaposi sarcoma (2003) (11)
Erratum: Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting (2017) (11)
Virus entry into host, establishment of infection, spread in host, mechanisms of tissue damage -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (11)
KSHV: forgotten but not gone. (2011) (11)
Aromatic amino acid methyl ester analogs form quinonoidal species with Dopa decarboxylase (1997) (11)
Establishing a KSHV1 Cell Line (BCP-1) From Peripheral Blood and Characterizing Its Growth in Nod/SCID Mice (1998) (10)
Early events in human cytomegalovirus infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (10)
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. (2002) (10)
Immediate–early viral gene regulation and function -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (9)
TRANSCRIPTION MAPPING OF KSHV IN A BODY CAVITY-BASED LYMPHOMA CELL LINE (BC-1) (1998) (9)
Molecular basis of HSV latency and reactivation -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (9)
Overview of classification -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (9)
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma (2004) (9)
Genetic comparison of human alphaherpesvirus genomes -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (8)
Antiviral therapy of HSV-1 and -2 -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (8)
Establishing a KSHV 1 Cell Line ( BCP-1 ) From Peripheral Blood and Characterizing Its Growth in Nod / SCID Mice (1998) (8)
Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. What is the current evidence for causality? (1997) (8)
Mitotic 4E-BP1 hyperphosphorylation and cap-dependent translation (2015) (8)
Human Herpesviruses: KSHV manipulation of the cell cycle and programmed cell death pathways (2007) (7)
Erratum: Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma (Journal of Virology 70:1 (551)) (1996) (7)
Maturation and egress -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (7)
Detection of bladder cancer by semi-automated microsatellite analysis of urine sediment. (2000) (7)
Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma (2018) (7)
Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy. (2004) (7)
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 (2004) (7)
Expression and characterization of a novel recombinant version of the secreted human mucin MUC5AC in airway cell lines. (2015) (7)
Human cytomegalovirus genome sequences in lymph nodes. (1999) (7)
Human gammaherpesvirus immune evasion strategies -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (6)
KSHV gene expression and regulation -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (6)
Kaposi's sarcoma--associated herpesvirus: a newly recognized pathogen. (1997) (6)
Transaldimination induces coenzyme reorientation in pig kidney dopa decarboxylase. (1995) (6)
Comparative genome and virion structure -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (6)
Gammaherpesviruses entry and early events during infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
Correction: Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E). (2019) (5)
Molecular basis of persistence and latency -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine (2022) (5)
EBV and KSHV – related herpesviruses in non-human primates -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
Early events pre-initiation of alphaherpes viral gene expression -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
Initiation of transcription and RNA synthesis, processing and transport in HSV and VZV infected cells -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
Two novel polymorphisms, c1086T>C and c1798C>T, in the MADH4/DPC4 gene (2000) (4)
Early viral gene expression and function -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
Preliminary X-ray analysis of a new crystal form of recombinant pig kidney DOPA decarboxylase. (1999) (4)
Modified purification of L-aromatic amino acid decarboxylase from pig kidney. (1993) (4)
Antiviral therapy of varicella-zoster virus infections -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
VZV: molecular basis of persistence (latency and reactivation) -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
Construction and characterization of two SARS‐CoV‐2 minigenome replicon systems (2022) (4)
DNA array/microarrays in oncological research with focus on pancreatic cancer. (2001) (4)
Immunobiology and host response to KSHV infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Alphaherpesvirus DNA replication -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
New directions in molecular techniques for pathogen identification. (1998) (3)
New approaches to antiviral drug discovery (genomics/proteomics) -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
VSV: persistence in the population -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
DNA synthesis and late viral gene expression -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Simian varicella virus -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Preliminary evaluation of hypochlorous acid spray for treatment of experimentally induced infectious bovine keratoconjunctivitis (2016) (3)
Merkel cell polyomavirus and non-small cell lung cancer (2013) (3)
Isolation and Evaluation of Anti-HIV Activity of Coumarins and Benzofurans from Werneria ciliolata and Werneria dactylophylla (1992) (3)
Envelopment of herpes simplex virus nucleocapsids at the inner nuclear membrane -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
ROUTE OF TRANSMISSION OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS: 2 (1997) (3)
Herpesviruses as therapeutic agents -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Monkey B virus -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Lack of integrin β5 in Merkel cell carcinomas and derived cell lines is frequently associated with Merkel cell polyomavirus positivity. (2012) (2)
Ago-associated human usRNAs and other similar small RNAs (2010) (2)
Dpc-4 is expressed in virtually all primary and metastatic pancreatic endocrine tumors (2002) (2)
Proteomic approach to discover human cancer viruses from formalin-fixed tissues (2020) (2)
Effects on apoptosis, cell cycle and transformation, and comparative aspects of EBV with other known DNA tumor viruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Gammaherpesviruses of New World primates -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Subversion of innate and adaptive immunity: immune evasion from antibody and complement -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Immunopathological aspects of HSV infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Varicella-zoster vaccine -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Herpes simplex vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Replication Kinetics for a Reporter Merkel Cell Polyomavirus (2022) (2)
Antiviral therapy for human cytomegalovirus -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
HCMV persistence in the population: potential transplacental transmission -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Mutation and Polymorphism Report (2000) (1)
Herpesvirus evasion of T-cell immunity -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Maintenance and replication during latency -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
The egress of alphaherpesviruses from the cell -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Effects on Protein Processing Evasion through Central Repeat Domain Mimics Epstein-Barr Virus EBNA1 Immune Latency-Associated Nuclear Antigen 1 Kaposi's Sarcoma-Associated Herpesvirus (2014) (1)
Short Communication Differential Viral Protein Expression in Kaposi's Sarcoma-Associated Herpesvirus-Infected Diseases Kaposi's Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman's Disease (2000) (1)
DNA vaccines for human herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Development and characterization of a new monoclonal antibody against SARS‐CoV‐2 NSP12 (RdRp) (2022) (1)
Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel‐Lindau gene in Italian patients (2000) (1)
Epstein–barr virus vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
PATHOGENS AND DISEASE: ISSUES IN DETERMINING CAUSALITY (2004) (1)
Mycoplasma and Epidemic Group A Meningococcal Meningitis-Reply (1991) (1)
Clinical and pathological aspects of EBV and KSHV infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Kaposi’s Sarcoma-Associated Herpesvirus: General Features (2008) (1)
Abstract CN09-04: Molecular methods for discovering human tumor viruses: Merkel cell polyomavirus (2008) (1)
Introduction to Diseases Associated with Kaposi’s Sarcoma-Associated Herpesvirus (2009) (1)
Human cytomegalovirus vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Faculty Opinions recommendation of Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. (2007) (1)
Candidate anti-herpesviral drugs; mechanisms of action and resistance -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Infectious Agents and Cancer (2007) (1)
Merkel c ell c arcinoma: i ncidence, Mortality, and r isk of Other c ancers (2010) (0)
Mutation of an active site tryptophan residue in DOPA decarboxylase (1997) (0)
Genome-wide allelotyping of pancreatic acinar cell and non-functional endocrine tumors (2000) (0)
PEPTIDE MAPPING AND EXPRESSION OF KSHV ORF73 (1998) (0)
Human Herpesviruses: Plate section (2007) (0)
151 Using genomics to search for new viral causes and treatments for human cancer (2014) (0)
The Role of Respiratory Infections in Epidemic Group A Meningococcal Meningitis (1991) (0)
ofCell Carcinoma Cells Require Expression Merkel Cell Polyomavirus-Infected Merkel (2010) (0)
Ks, Kshv and the Molecular Case for Causation (2006) (0)
Non-human primate herpesviruses (2007) (0)
Faculty Opinions recommendation of Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. (2007) (0)
Risk of specific lymphoma subtypes is associated to polymorphism in genes implicated in the metabolism of workplace carcinogens (2011) (0)
Faculty Opinions recommendation of Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. (2007) (0)
Immunotherapy of HSV infections – antibody delivery -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (0)
Faculty Opinions recommendation of Herpes simplex virus encephalitis in human UNC-93B deficiency. (2006) (0)
MYCOPLASMA AND EPIDEMIC GROUP A MENINGOCOCCAL MENINGITIS. AUTHOR'S REPLY (1991) (0)
Human Herpesvirus 8 ORF 50 is Encoded in a Bi-Cistronic Message (1998) (0)
Mitotic CDK1 and 4E-BP1 II: A single phosphomimetic mutation in 4E-BP1 induces glucose intolerance in mice (2023) (0)
Adoptive immunotherapy for herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (0)
Mitotic CDK1 and 4E-BP1 I: Loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice (2023) (0)
POSTTRANSPLANTATION PLASMACYTIC PROLIFERATION RELATED TO KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS (1998) (0)
Comment on Uldrick et al , page 6977 KSHV : forgotten but not gone (2011) (0)
MCV status does not impact on histological and clinical characteristics of european and australian merkel cell carcinomas (2010) (0)
Yuan latency antigen inhibit viral persistence in lymphoma cells Intrabodies targeting the Kaposi sarcoma – associated herpesvirus (2005) (0)
Primary Effusion Lymphoma Cells Associated Herpesvirus Latency in − Sarcoma Induction and Maintenance of Kaposi Role of IRF 4 in IFN-Stimulated Gene (2013) (0)
Multicolor miRNA fluorescence in situ hybridization for tumor differential diagnosis (2013) (0)
Genetics of gastric cancer: clinical implications. (2003) (0)
[The anatomical pathologist and the diagnosis of genetic risk]. (2000) (0)
Faculty Opinions recommendation of Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. (2007) (0)
Abstract PR5: Human Merkel cell polyomavirus causes Merkel cell carcinoma: Implication of viral etiology in human cancers (2011) (0)
Faculty Opinions recommendation of Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. (2012) (0)
Faculty Opinions recommendation of Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. (2009) (0)
Kaposi's Sarcoma Findings (1995) (0)
latency antigen inhibit viral persistence in lymphoma cells Intrabodies targeting the Kaposi sarcoma-associated herpesvirus (2008) (0)
GuCI-induced unfolding of pig kidney dopa decarboxylase: Evidence for a multi-state process (1994) (0)
Human Herpesviruses: Preface (2007) (0)
156 What Happens When Your Viral Flora Gives You Cancer (2012) (0)
Basic virology and viral gene effects on host cell functions: gammaherpesviruses (2007) (0)
Molecular pathways implicated in pancreatic ductal cancer are not involved in exocrine nonductal or endocrine tumorigenesis (2000) (0)
Rapid rational drug targeting of Merkel cell polyomavirus (MCV)-positive Merkel cell carcinoma (MCC) using the survivin inhibitor YM155. (2012) (0)
Kaposi sarcoma transferred through organ transplantation (2003) (0)
KSHV-encoded oncogenes and oncogenesis.: S13 (1997) (0)
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens (cid:1) (2010) (0)
Role of IRF 4 in IFN-stimulated gene induction and maintenance of KSHV latency in primary effusion lymphoma cells (2013) (0)
Faculty Opinions recommendation of Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. (2006) (0)
at the 40th Annual American Society of Hematology Meeting, December 7, part Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 : Presented in Angiogenesis and Hematopoiesis Induced by Kaposi's (2013) (0)
Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV8) (2017) (0)
Human Herpesviruses: List of contributors (2007) (0)
A Rapid in Vitro Assay for Detecting Phorbol Ester-Like Tumor Promoters (1983) (0)
Abstract IA38: Viral cancers: The forgotten culprits in the African cancer problem (2017) (0)
Observations on theinhibition ofHIV-1reversetranscriptase by catechins (1992) (0)
Sulphasalazine Increases Fibrinolysis in the Anaesthetised Rat (1988) (0)
Pathogenesis, clinical disease, host response, and epidemiology: gammaherpesviruses (2007) (0)
Faculty Opinions recommendation of KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. (2006) (0)
Faculty Opinions recommendation of Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization. (2008) (0)
Faculty Opinions recommendation of Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Patrick S Moore?

Patrick S Moore is affiliated with the following schools:

Patrick S Moore's Academic­Influence.com Rankings

Patrick S Moore's Degrees

Similar Degrees You Can Earn

Why Is Patrick S Moore Influential?

Patrick S Moore's Published Works

Published Works

What Schools Are Affiliated With Patrick S Moore?

Patrick S Moore's AcademicInfluence.com Rankings